Paola Andrea Rueda, Sara Orozco, Juan Raúl Castro, Ángela María Londoño, Elsa María Vásquez, Andrea Arango, Carlos Esteban Builes
{"title":"Incidence and prevalence of vitiligo by gender and age in the Colombian population","authors":"Paola Andrea Rueda, Sara Orozco, Juan Raúl Castro, Ángela María Londoño, Elsa María Vásquez, Andrea Arango, Carlos Esteban Builes","doi":"10.7705/biomedica.7522","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Vitiligo is an acquired depigmenting skin disorder characterized by achromic macules resulting from the selective destruction of melanocytes. Epidemiological information regarding this condition remains limited in Colombia and Latin America, with prevalence varying across geographical regions.</p><p><strong>Objective: </strong>To estimate the incidence and prevalence of vitiligo in Colombia by age, gender, and region.</p><p><strong>Materials and methods: </strong>A retrospective study was conducted utilizing real-world clinical practice data retrieved from the national registry SISPRO (Sistema de Información para la Protección Social) spanning the period from 2015 to 2022.</p><p><strong>Results: </strong>Over the eight-year follow-up period (2015-2022) in Colombia, 131,494 patients were diagnosed with vitiligo. In 2016, the lowest incidence was observed, with 26 cases per 100,000 inhabitants, whereas in 2019, the highest incidence was recorded at 47 cases per 100,000 inhabitants, representing a difference of 11,175 cases between the two years. Incidence decreased in 2020 to 28.15 cases per 100,000 inhabitants. Prevalence exhibited a linear increase over the years, with the highest rates observed in 2018 and 2019.</p><p><strong>Conclusions: </strong>This study represents the first comprehensive report on epidemiological data concerning individuals with vitiligo in Colombia, and the second in South America. It contributes to the understanding of this condition, revealing an upward trend in incidence and prevalence. These findings also provide insights into primary treatment modalities, which are probably associated with improved case registration by healthcare providers.</p>","PeriodicalId":101322,"journal":{"name":"Biomedica : revista del Instituto Nacional de Salud","volume":"45 4","pages":"566-573"},"PeriodicalIF":0.6000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12542889/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedica : revista del Instituto Nacional de Salud","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7705/biomedica.7522","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Vitiligo is an acquired depigmenting skin disorder characterized by achromic macules resulting from the selective destruction of melanocytes. Epidemiological information regarding this condition remains limited in Colombia and Latin America, with prevalence varying across geographical regions.
Objective: To estimate the incidence and prevalence of vitiligo in Colombia by age, gender, and region.
Materials and methods: A retrospective study was conducted utilizing real-world clinical practice data retrieved from the national registry SISPRO (Sistema de Información para la Protección Social) spanning the period from 2015 to 2022.
Results: Over the eight-year follow-up period (2015-2022) in Colombia, 131,494 patients were diagnosed with vitiligo. In 2016, the lowest incidence was observed, with 26 cases per 100,000 inhabitants, whereas in 2019, the highest incidence was recorded at 47 cases per 100,000 inhabitants, representing a difference of 11,175 cases between the two years. Incidence decreased in 2020 to 28.15 cases per 100,000 inhabitants. Prevalence exhibited a linear increase over the years, with the highest rates observed in 2018 and 2019.
Conclusions: This study represents the first comprehensive report on epidemiological data concerning individuals with vitiligo in Colombia, and the second in South America. It contributes to the understanding of this condition, revealing an upward trend in incidence and prevalence. These findings also provide insights into primary treatment modalities, which are probably associated with improved case registration by healthcare providers.
简介:白癜风是一种获得性脱色性皮肤疾病,其特征是由于黑色素细胞的选择性破坏而产生色斑。在哥伦比亚和拉丁美洲,关于这种疾病的流行病学信息仍然有限,不同地理区域的流行率各不相同。目的:按年龄、性别和地区估计哥伦比亚白癜风的发病率和患病率。材料和方法:一项回顾性研究利用从国家登记处SISPRO (Sistema de Información para la Protección Social)检索的2015年至2022年期间的真实临床实践数据进行。结果:在哥伦比亚的8年随访期间(2015-2022年),131,494名患者被诊断为白癜风。2016年的发病率最低,为每10万居民26例,而2019年的发病率最高,为每10万居民47例,两年间的差异为11175例。到2020年,发病率下降到每10万居民28.15例。多年来,患病率呈线性增长,2018年和2019年的发病率最高。结论:本研究是哥伦比亚白癜风患者流行病学资料的第一份综合报告,也是南美洲的第二份报告。它有助于了解这种情况,揭示了发病率和患病率的上升趋势。这些发现还提供了对初级治疗方式的见解,这可能与医疗保健提供者改善病例登记有关。